FRONTIER THERAPEUTICS LIMITED
Get an alert when FRONTIER THERAPEUTICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2027-04-13 (in 11mo)
Last made up 2026-03-30
Watchouts
None on the register
Cash
£2M
+39.6% vs 2024
Net assets
£26M
+11.8% vs 2024
Employees
111
-4.3% vs 2024
Profit before tax
£4M
-27.2% vs 2024
Name history
Renamed 2 times since incorporation
- FRONTIER THERAPEUTICS LIMITED 1997-05-22 → present
- FRONTIER MEDICAL PRODUCTS LIMITED 1990-12-11 → 1997-05-22
- NOTIONSTATUS LIMITED 1990-10-25 → 1990-12-11
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £19,320,000 | £17,373,000 | |
| Operating profit | £5,127,000 | £3,730,000 | |
| Profit before tax | £5,127,000 | £3,730,000 | |
| Net profit | £4,863,000 | £2,594,000 | |
| Cash | £1,202,000 | £1,678,000 | |
| Total assets less current liabilities | £23,227,000 | £26,097,000 | |
| Net assets | £23,077,000 | £25,800,000 | |
| Equity | £23,077,000 | £25,800,000 | |
| Average employees | 116 | 111 | |
| Wages | £4,785,000 | £4,265,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | 26.5% | 21.5% | |
| Net margin | 25.2% | 14.9% | |
| Return on capital employed | 22.1% | 14.3% | |
| Gearing (liabilities / total assets) | 21.8% | 24.7% | |
| Current ratio | 4.41x | 3.95x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence in the foreseeable future.”
Group structure
- FRONTIER THERAPEUTICS LIMITED · parent
- Genie Care Limited 100%
- Frontier Therapeutics Inc 100%
Significant events
- “A material customer, NRS Healthcare, entered administration on 1 August 2025. The revenue associated with this customer is migrating to other service providers, and management expect to recover the lost turnover. As at 31 March 2025 there was a balance of £31,000 which management consider a doubtful debt.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BAMBERY, Matthew James | Secretary | 2025-11-14 | — | — |
| BAMBERY, Matthew James | Director | 2013-12-05 | May 1978 | British |
| CALDWELL, David George Mawdsley | Director | 2025-02-20 | Jun 1975 | British |
| JACKSON, Mark Bentley | Director | 2021-09-24 | Nov 1956 | British |
| PHILLIPS, Mark | Director | 2022-04-20 | Nov 1968 | British |
| YANG, Teo Heng Jimmy | Director | 2024-04-02 | May 1968 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BAMBERY, Matthew James | Secretary | 2013-12-05 | 2024-03-04 |
| HARRIS, Nigel | Secretary | — | 2013-12-05 |
| THORNTON, Matthew Thomas | Secretary | 2024-03-04 | 2025-11-14 |
| ANTHONY, John Edgar | Director | — | 2002-09-02 |
| CLANCY, Michael John | Director | 2006-05-31 | 2011-09-23 |
| DAVIS, Nicholas John Stratton | Director | 1998-02-01 | 2014-12-19 |
| HARRIS, John | Director | — | 2006-05-25 |
| HARRIS, Nigel | Director | — | 2021-05-31 |
| JACKSON, Simon Timothy | Director | 2014-03-17 | 2021-11-10 |
| THORNTON, Matthew Thomas | Director | 2024-03-04 | 2025-11-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Frontier Medical Products Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 154 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-03-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-03-05 | CH01 | officers | Change person director company with change date | |
| 2025-12-23 | AA | accounts | Accounts with accounts type full | |
| 2025-11-14 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-11-14 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-14 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-03-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-21 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-03-18 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-02-24 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-12 | CH01 | officers | Change person director company with change date | |
| 2025-02-12 | CH03 | officers | Change person secretary company with change date | |
| 2024-11-22 | AA | accounts | Accounts with accounts type full | |
| 2024-05-16 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-16 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-05-16 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-21 | AA | accounts | Accounts with accounts type full | |
| 2023-04-04 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
-10.1%
£19,320,000 £17,373,000
-
Cash
+39.6%
£1,202,000 £1,678,000
-
Net assets
+11.8%
£23,077,000 £25,800,000
-
Employees
-4.3%
116 111
-
Operating profit
-27.2%
£5,127,000 £3,730,000
-
Profit before tax
-27.2%
£5,127,000 £3,730,000
-
Wages
-10.9%
£4,785,000 £4,265,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers